Series C · AI & Machine Learning · Cambridge, United Kingdom · Founded 2014 · 51–200 employees
Healx is an AI-powered biotech company pioneering next-generation drug discovery for rare diseases. Founded in 2014 by Tim Guilliams and David Brown (co-inventor of Viagra), the company uses its proprietary generative AI platform called Healnet to identify novel connections between existing drugs and rare diseases. With over 7,000 rare diseases affecting 400 million people globally but only 5% having approved treatments, Healx addresses a massive unmet need. The company has raised $47 million in Series C funding and achieved significant clinical progress with its AI-discovered NF1 treatment HLX-1502 receiving FDA Orphan Drug Designation and entering Phase 2 trials.